Home
/
NowPatient Blog
/
How did HIV start?

How did HIV start?

Stefano Mirabello NowPatientGreen tick
Created on 16 Jul 2024
Updated on 16 Jul 2024

Understanding the evolution of HIV (Human Immunodeficiency Virus) involves tracing a complex timeline that spans continents and species. HIV-1, the virus most commonly associated with AIDS (Acquired Immune Deficiency Syndrome), and HIV-2 both have their roots in viruses infecting African primates, with HIV-1 originating from a chimpanzee subspecies and HIV-2 from the sooty mangabey, shedding light on the critical cross-species transmission events that have shaped the modern epidemic.

This article will navigate through the timeline of HIV’s emergence, highlighting key moments from its jump from animals to humans to its spread among communities. The journey not only uncovers the historical trajectory of the virus but also emphasizes the importance of understanding its origins to inform future prevention and treatment strategies.

Tracing the origins: Early clues and scientific investigations

HIV-1, the predominant cause of the global HIV epidemic, has its origins traced back to chimpanzees, revealing a complex journey of cross-species transmission. This virus is closely related to simian immunodeficiency viruses (SIVs) found in wild-living chimpanzees and gorillas in West Central Africa. Through four distinct lineages, HIV-1 emerged from SIVs, with at least one lineage involving gorillas. These lineages highlight the virus’s adaptability and the critical role of cross-species transmission in its evolution.

Origins and cross-species transmission:

  • Chimpanzee to human: HIV-1 originated from SIVcpz, found in chimpanzees. It has undergone three separate transfers to humans
  • Gorilla involvement: At least one or two transmissions of HIV-1 to humans may have involved gorillas, showcasing the complexity of its origins
  • SIV diversity: Over 40 species of African monkeys are infected with their own species-specific SIV, indicating a vast reservoir of these viruses

Genetic evolution and pathogenicity:

  • Chimpanzees acquired two distinct forms of SIVs, which recombined to create a virus leading to AIDS
  • The adaptation of monkey viruses first to chimpanzees and then to humans highlights the genetic changes crucial for understanding the pathogenicity of HIV

Epidemiological Insights:

  • The discovery that SIVcpz is pathogenic in its natural host challenges previous notions and provides insights into the virus’s impact on chimpanzee populations
  • Molecular clock analyses date the onset of the group M and O HIV-1 epidemics to the early twentieth century, offering a timeline for the spread of the virus among humans

This examination of HIV-1’s origins underscores the importance of understanding its evolution for developing effective prevention and treatment strategies.

The jump from animals to humans: The critical cross-species transmission

The critical jump from animals to humans marks a pivotal moment in the history of HIV, underscoring the complex interplay between species that led to the emergence of HIV-1, the virus responsible for AIDS in humans. This transition involved several key events:

Cross-species transmission events:

  • From monkeys to chimpanzees: The simian immunodeficiency virus (SIV) in chimpanzees is a hybrid virus, originating from two different viruses that jumped from red-capped mangabeys and greater spot-nosed monkeys into chimpanzees. This hybridization likely occurred as chimps consumed these monkeys, incorporating the viruses into their own genetic makeup
  • From chimpanzees to humans: The hybrid virus spread within the chimpanzee population before making the leap to humans, evolving into what is now known as HIV-1

Genetic evolution and diversification:

  • Following its transmission to humans, HIV-1 underwent significant genetic evolution, a process evidenced by the non-synonymous variants observed in viral genomes across different time points. This evolution played a crucial role in the virus’s adaptability and pathogenicity in humans
  • The recombination of various SIVs is believed to have facilitated the cross-species transmission and subsequent diversification of HIV-1, particularly within group M subtypes. This diversification was notably observed in Kinshasa in the early twentieth century

Implications of Zoonotic transmission:

  • The transmission of viruses from animals to humans is not unique to HIV but is a phenomenon observed in other diseases such as Ebola, Zika, and coronaviruses. Non-human primates (NHPs) serve as a reservoir for numerous pathogens, including retroviruses like SIV, that can jump to humans through activities such as hunting and butchering
  • Understanding the zoonotic origins of HIV, from SIVcpz endemic in West Central African chimpanzees to its global spread infecting over 33 million people, highlights the importance of studying cross-species transmission to prevent future zoonoses

This examination of the jump from animals to humans not only sheds light on the origins of HIV but also emphasizes the critical role of genetic evolution and human activities in the spread of zoonotic diseases.

The earliest known cases of HIV in humans

Time-stamped cases of HIV-2:

  • The time to the most recent common ancestor (tMRCA) for HIV-2 group A is estimated around 1932, with a possible range from 1906 to 1955
  • For HIV-2 group B, tMRCA is approximated to be 1935, with an earlier limit of 1907 and a later limit of 1961

Initial documented cases of HIV-1:

  • The first known case of HIV-1 in humans was detected in a male from Kinshasa, Congo, in 1959. This case underscores the presence of the virus in humans well before the global recognition of the AIDS epidemic
  • An adult Bantu male from Kinshasa, identified through the sample LEO70 in 1959, represents the earliest known sample of HIV-1, indicating the virus’s presence in the Democratic Republic of the Congo during that period
  • A Scandinavian man who had travelled to west-central Africa was identified in the 1960s as the first patient with HIV infection and AIDS, highlighting the disease’s existence outside of Africa at an early stage

Further historical cases and spread:

  • The Centers for Disease Control and Prevention (CDC) recorded the first 50,000 cases of AIDS from 1981 to 1987, with the subsequent 50,000 cases reported within a span of less than two years, between December 1987 and July 1989, signaling a rapid escalation of the epidemic
  • In 1978, a Portuguese man treated in London was confirmed to have HIV-2, marking a significant case in the disease’s history within Europe
  • The United States saw its first recorded case of AIDS with the death of Robert Rayford, a 16-year-old, in 1969, which retrospectively indicated that the virus had spread to North America earlier than initially thought
  • The earliest verified case of HIV comes from a 1959 blood sample of a man in Kinshasa, further confirming the virus’s existence in the human population during the mid-20th century

The timeline of HIV’s emergence in humans

The timeline of HIV’s emergence in humans is marked by pivotal events that have shaped our understanding and response to the epidemic. These milestones, from the initial reporting to groundbreaking medical advancements, provide a structured overview of the virus’s impact on society and healthcare.

  • 1981: The U.S. Center for Disease Control (CDC) reports the first cases of what would later become known as the AIDS epidemic
  • 1982: The CDC reports the first cases of AIDS in women and hosts the first conference to address the new epidemic
  • 1985: A landmark year with several firsts:
  • The U.S. Food and Drug Administration licenses the first blood test to detect HIV
  • The first International AIDS Conference is held in Atlanta, Georgia
  • The first cases of AIDS among children under age 13 are reported
  • Rock Hudson becomes the first major U.S. public figure to announce he had AIDS
  • Dwight Burk is born as the first child of a haemophiliac with AIDS
  • 1987:
  • The first panel of the AIDS Memorial Quilt is created
  • AZT becomes the first antiretroviral drug available to treat HIV
  • 1988: The first World AIDS Day is observed
  • 1992: Introduction of the first combination drug therapies for HIV
  • 2013: The first well-documented case of an HIV-infected child appears to be cured of HIV
  • 2019: The first living donor HIV-to-HIV kidney transplant in the U.S. occurs

This sequence of events, from the early reports in the 1980s to significant medical milestones in the 2010s, highlights the critical steps taken in understanding and combating HIV. The timeline not only reflects the scientific and medical community’s efforts but also underscores the societal impact, marking periods of fear, stigma, and eventually, hope.

Implications of understanding HIV’s origins

Understanding the rapid evolution of HIV is pivotal in grasping why combatting this virus presents such a significant challenge. Key factors contributing to this rapid evolution include:

  • Error-prone reverse transcriptase: Lacking proofreading activity, this enzyme introduces mutations during viral replication, contributing to the virus’s high mutation rate
  • Recombination: This occurs when viruses within a patient exchange genetic material. The impact depends on the viruses’ divergence
  • Short generation times: Accelerate the rate of viral evolution, leading to extensive diversity

This diversity hinders the immune system’s ability to eradicate the virus and complicates the development of effective drugs and vaccines. The challenge is underscored by the fact that few candidate vaccines have reached phase III trials, and none have shown efficacy. This situation is attributed to HIV’s ability to mutate rapidly, creating a “moving target” that eludes current vaccine development efforts.

Recent technological advances, such as next-generation sequencing (NGS), have provided deeper insights into HIV’s evolution, revealing:

  • High mutation rates: HIV exhibits the highest biological mutation rate known, with significant interpatient genome-wide nucleotide substitution rates
  • Unique recombinant forms (URF) and circulating recombinant forms (CRF): Arise from recombination events, complicating the viral landscape

These insights emphasize the need for a nuanced understanding of HIV’s origins and evolutionary mechanisms. Such knowledge is crucial for the development of targeted vaccines and therapies, addressing misconceptions, and formulating effective strategies for HIV/AIDS control and eradication.

Conclusion

Tracing the complex journey from HIV’s origins in African primates to its current status as a global epidemic illuminates not only the virus’s adaptability and resilience, but also underscores the critical importance of scientific inquiry in understanding zoonotic diseases. The shared insights from decades of research have not only mapped the historical trajectory of HIV but also laid the groundwork for future strategies in prevention, treatment, and possibly eradication. This narrative, woven through the article, highlights our collective challenges and triumphs in facing one of the modern era’s most formidable health crises. It underscores the necessity of embracing both the historical context and the evolutionary biology of HIV to navigate the path ahead effectively.

As we reflect on the significance of understanding HIV’s origins and its epidemiological journey, it becomes evident that this knowledge is pivotal for the ongoing fight against the virus. The implications extend beyond the realm of public health, touching on aspects of human behavior, societal norms, and international cooperation. The evolution of HIV serves as a stark reminder of the interconnectedness of humans and the natural world, emphasizing the need for vigilance, continued research, and a globally coordinated response to infectious diseases. It is through such comprehensive understanding and collaboration that we can hope to curb the impact of HIV and prepare ourselves for future challenges that may arise from our ever-changing relationship with the natural world.

Sources

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

What is the origin and development of HIV?

The evolutionary history of HIV points to chimpanzees as the initial carriers of the virus group HIV-1. From these primates, HIV-1 has branched into four distinct lineages due to separate instances of cross-species transmission to humans. There is also evidence suggesting that some of these transmissions may have involved gorillas as intermediaries.

 

Can you describe the different phases of the HIV life cycle?

The HIV life cycle consists of seven distinct stages:

  • Binding to the host cell
  • Fusion with the cell membrane
  • Reverse transcription of its RNA into DNA
  • Integration of this DNA into the host’s genome
  • Replication within the host cell
  • Assembly of new virus particles, and
  • Budding, where new viral particles exit the host cell. To fully comprehend the life cycle, it is beneficial to visualize the structure of the HIV virus

 

What is a common timeline for HIV infection?

The typical progression of HIV infection starts with initial symptoms, which often subside. Following this, an individual may experience a symptom-free period that can last many years, even up to a decade. Despite the absence of symptoms, the virus remains active during this time, gradually undermining the immune system. The duration of this asymptomatic period can vary widely among individuals.

 

How does HIV progress through its stages?

HIV infection progresses through three main stages:

  • Acute HIV infection, which is the initial phase
  • Chronic HIV infection, which is a prolonged phase with the virus actively replicating, and
  • Acquired immunodeficiency syndrome (AIDS), is the most severe phase of the infection. While there is no cure for HIV, antiretroviral therapy (ART) can significantly slow down the progression from one stage to another, helping to manage the condition

 

When did the World Health Organization first define AIDS?

The World Health Organization (WHO) initially proposed a definition for AIDS in 1986. This classification has been revised and refined over the years, with the latest update released in 2007.

How does HIV infection progress over time?

HIV infection progresses through three main stages: (1) acute HIV infection, which is the initial phase, (2) chronic HIV infection, where the virus is less symptomatic but still active, and (3) acquired immunodeficiency syndrome (AIDS), the most severe phase. While there is no cure for HIV, antiretroviral therapy (ART) can significantly slow down the progression from one stage to the next.

Who was the first known person to contract AIDS, and how did it happen?

The first known case of HIV-1 was detected in a male from Kinshasa, Congo, in 1959, though his identity remains unknown. The first patient to be officially diagnosed with HIV infection and AIDS was a Scandinavian man in the 1960s who had traveled to west-central Africa.

Now Patient Data Security

Data Security

Our Commitment to You.

Learn moreNow Patient Data SecurityNow Patient Data Security

WHY WE BUILT NOWPATIENT

We are committed to helping everyone, everywhere live healthier lives

The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.

Download our app today

NowPatient dashboard

Your Questions Answered

For your peace of mind, we can answer your questions quickly

What does NowPatient do?

NowPatient is an online pharmacy & telehealth service that is available in the US and UK. Our service is FREE and packed with useful features that can help you save money on the cost of your medications, access virtual treatments, and provide tools that can help improve your overall health.

Get started today and benefit from medication remindersGet Treated PrivatelyNHS online pharmacyGP appointment bookingRx savings cardDrug CouponsUS drug savings programshealth conditions informationgenetic testinghome test kitsBMI RisksType 2 Diabetes Riskspollen meterair quality monitor, and lots more!

Our service is operated by experienced medical professionals in the United States and the United Kingdom. You can view the online services that we provide by clicking Features.

UK users can safely and securely buy medicines online that treat a wide range of medical conditions. UK customers can also order NHS prescriptions online with the benefit of free tracked delivery.

US customers, regardless of insurance coverage, can enjoy huge savings on prescription medications using our various drug savings programs including drug coupons, savings card and manufacturer-sponsored patient assistance programs.

Where is NowPatient located?

NowPatient has offices in the United Kingdom and United States.

In the UK, we are located at:

NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA

In the US, we are located at:

NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX

How can I contact NowPatient?

To contact NowPatient, please use the contact form available on the Contact Us page.

Alternatively, if you need to speak to us, you can reach us on the following numbers:

UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977

Who owns NowPatient?

NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.

Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).

Can you tell me more about your NHS online pharmacy?

NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.

Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).

Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.

How do I make a complaint?

From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.

Can you tell me more about NowPatient’s prescribing services for treatments offered?

Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:

• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old

NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla.

Can you tell me more about NowPatient’s US services?

Our head of US services is Dr. Jamie Winn.

You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.

We do not provide any prescribing services or dispensing services in the United States.

Is NowPatient legit and can I trust information from NowPatient?

Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.

NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.

Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:

NowPatient Trustpilot

What are NowPatient’s opening hours?

Our office hours are:

UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST

Please note that we are closed at weekends.

In the event of a medical life-threatening emergency please call:

UK – 999
US – 911

In the event of a medical emergency which is not life-threatening please call:

UK – 111

Find more answers